Teewinot's Executive Vice President Dr. Richard Peet stated that "Teewinot's Irish subsidiary, FSL, owns a rapidly expanding patent portfolio covering processes for manufacture of cannabinoids, cannabinoid prodrugs and cannabinoid analogs. FSL's patent portfolio also covers novel cannabinoid prodrugs, cannabinoid analogs and treatment therapies. With federally licensed laboratories in Canada, an Irish subsidiary, and global headquarters in Tampa, Florida, Teewinot is well positioned to be a worldwide leader in the manufacture and delivery of cannabinoid-based therapies."
About Teewinot Life Sciences Corporation
Teewinot Life Sciences Corporation is an international biopharmaceutical company focused on the use of novel biosynthetic processes such as biocatalysis and synthetic biology, as well as sophisticated formulation technologies, for the production and delivery of cannabinoid-based therapies. With headquarters in Tampa, Florida, Teewinot is an industry leader in the development and implementation of technologies for the cost-effective manufacture of pharmaceutically pure authentic cannabinoids. Teewinot's global technology and intellectual property portfolio represent a breakthrough in the manufacture and delivery of cannabinoid-based pharmaceuticals. For more information, please visit www.tlscorp.com or follow us on Twitter (@teewinot_corp).
For More Information:
Teewinot Life Sciences Corporation
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teewinot-life-sciences-irish-subsidiary-full-spectrum-laboratories-ltd-secures-a-new-us-patent-for-biosynthesis-of-cannabinoids-300384569.html
SOURCE Teewinot Life Sciences Corporation